OSSIO Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 149

Employees

  • Latest Deal Type
  • General Corporate Purpose

  • Investors
  • 8

OSSIO General Information

Description

Operator of an orthopedic fixation company intended to provide the first credible replacement for metal implants. The company's fixation devices utilize intelligent bone regeneration technology and are based on a biocomposite material platform and also offer reinforcing mineral fibers made of a mineral blend, enabling patients to regenerate tissues and bones and recover from orthopedic disorders.

Contact Information

Website
www.ossio.io
Formerly Known As
Resorbium
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 300 TradeCenter Drive
  • Suite 3690
  • Woburn, MA 01801
  • United States
+1 (833)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 300 TradeCenter Drive
  • Suite 3690
  • Woburn, MA 01801
  • United States
+1 (833)

OSSIO Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OSSIO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. General Corporate Purpose 20-Jan-2026 Completed Generating Revenue
5. Later Stage VC (Series D) 02-Dec-2024 Completed Generating Revenue
4. Later Stage VC (Series C) 17-Oct-2022 Completed Generating Revenue
3. Later Stage VC 22-Mar-2021 Completed Generating Revenue
2. Later Stage VC 11-Mar-2019 $22M $14.6M Completed Generating Revenue
1. Early Stage VC 15-Jul-2016 $2.98M $2.98M Completed Generating Revenue
To view OSSIO’s complete valuation and funding history, request access »

OSSIO Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred D Shares
Preferred C-3 Shares,
Preferred C-2 Shares
Preferred C-1 Shares
Preferred A-3 Shares
Preferred A-2 Shares
Preferred A-1 Shares 176,040 $16.68 $16.68 1x $16.68 2.46%
Ordinary A 220,265 $13.53 $13.53 1x $13.53 3.08%
To view OSSIO’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

OSSIO Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an orthopedic fixation company intended to provide the first credible replacement for metal implants. The co
Surgical Devices
Woburn, MA
149 As of 2026

Warsaw, IN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OSSIO Competitors (1)

One of OSSIO’s competitors is DePuy Synthes, a Corporate Backed or Acquired company based in Warsaw, IN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DePuy Synthes Corporate Backed or Acquired Warsaw, IN
You’re viewing 1 of 1 competitors. Get the full list »

OSSIO Patents

OSSIO Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026053204-A1 Fiber-reinforced fully threaded implant Pending 03-Sep-2024
US-12702443-B2 Subchondral bone defect treatment Active 06-Mar-2023
US-20240299063-A1 Subchondral bone defect treatment Active 06-Mar-2023
US-20260345203-A1 Subchondral bone defect treatment Pending 06-Mar-2023
AU-2023380290-A1 Fiber-reinforced orthopedic compression staple Pending 16-Nov-2022 A61B17/064
To view OSSIO’s complete patent history, request access »

OSSIO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OSSIO Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Questa Capital Venture Capital Minority
MVM Partners Growth/Expansion Minority
Courage Capital Management Lender/Debt Provider Minority
Arc Ventures (United States) Venture Capital Minority
OCV Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

OSSIO FAQs

  • When was OSSIO founded?

    OSSIO was founded in 2014.

  • Where is OSSIO headquartered?

    OSSIO is headquartered in Woburn, MA.

  • What is the size of OSSIO?

    OSSIO has 149 total employees.

  • What industry is OSSIO in?

    OSSIO’s primary industry is Surgical Devices.

  • Is OSSIO a private or public company?

    OSSIO is a Private company.

  • What is OSSIO’s current revenue?

    The current revenue for OSSIO is .

  • How much funding has OSSIO raised over time?

    OSSIO has raised $158M.

  • Who are OSSIO’s investors?

    Questa Capital, MVM Partners, Courage Capital Management, Arc Ventures (United States), and OCV Partners are 5 of 8 investors who have invested in OSSIO.

  • Who are OSSIO’s competitors?

    DePuy Synthes is a competitor of OSSIO.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process